kabutan

KAINOS Laboratories,Inc.(4556) Summary

4556
TSE Standard
KAINOS Laboratories,Inc.
1,283
JPY
+11
(+0.86%)
Jan 29, 2:29 pm JST
8.38
USD
Jan 29, 12:29 am EST
Result
PTS
outside of trading hours
1,274
Jan 29, 12:52 pm JST
Summary Chart Historical News Financial Result
PER
9.0
PBR
0.76
Yield
2.49%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,286 JPY 8.39 USD
Previous Close Jan 28
1,272 JPY 8.33 USD
High Jan 29, 9:00 am
1,286 JPY 8.39 USD
Low Jan 29, 9:09 am
1,272 JPY 8.31 USD
Volume
900
Trading Value
1.00M JPY 7.51K USD
VWAP
1278.44 JPY 8.34 USD
Minimum Trading Value
128,300 JPY 838 USD
Market Cap
5.85B JPY 0.04B USD
Number of Trades
7
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly Low
1-Year Average
14
1-Year High Apr 28, 2025
198
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 63,500
Jan 16, 2026 0 62,300
Jan 9, 2026 0 63,700
Dec 26, 2025 0 60,600
Dec 19, 2025 0 56,800
Company Profile
KAINOS Laboratories, Inc. is a mid-tier clinical diagnostics company specializing in renal function and allergy tests, with a focus on biochemistry and immunoserology.
Sector
Pharmaceuticals
KAINOS Laboratories, Inc. primarily engages in the manufacture and sale of in vitro diagnostic reagents and medical devices for clinical testing. The company operates independently without subsidiaries or affiliates, maintaining a continuous and close business relationship with Asahi Kasei Pharma. In the field of clinical diagnostics, KAINOS's main products include those for renal function and blood transfusion tests. The company particularly excels in biochemical and immunoserological testing, demonstrating its strengths in these areas. By providing essential products for diagnosis and treatment decisions in medical settings, KAINOS contributes to improving the quality of healthcare.